Conference item icon

Conference item

Intravenous immune globulin in chronic lymphocytic leukaemia.

Abstract:

The most common complication of chronic lymphocytic leukaemia (CLL) is infection, which occurs mainly in advanced stages of disease or in those patients with hypogammaglobulinaemia. Intravenous immune globulin (IVIG) has been shown to be a useful prophylactic therapy against infections in such patients. A randomized, double-blind study on 36 patients receiving either 500 mg/kg or 250 mg/kg IVIG every 4 weeks was undertaken to determine the dose regimen required. There was no significant diffe...

Expand abstract
Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
NDM Experimental Medicine
Role:
Author
Expand authors...
Volume:
97 Suppl 1
Pages:
17-20
Host title:
Clinical and experimental immunology
Publication date:
1994-07-01
Event location:
ENGLAND
EISSN:
1365-2249
ISSN:
0009-9104
Source identifiers:
66982
Keywords:
Pubs id:
pubs:66982
UUID:
uuid:41cebeee-daf5-4943-965f-f27bd9c74a63
Local pid:
pubs:66982
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP